Pacira | PCRX - Passifs Courants





Passifs Courants Changement Date
Astellas Pharma JPY 1.1T 134.96B 2026-09
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Cara Therapeutics USD 11.26M 216K 2026-03
Coherus Biosciences USD 75.51M 56.82M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Ironwood Pharmaceuticals USD 34.73M 1.88M 2026-09
J&J USD 55.46B 562M 2026-09
Ligand Pharmaceuticals USD 500.57M 453.83M 2026-09
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novo Nordisk DKK 239.08B 13.92B 2026-06
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 126.1M 4.08M 2026-09
Perrigo USD 1.02B 34.4M 2026-09
Pfizer USD 31.73B 920M 2026-09
Supernus Pharmaceuticals USD 285.4M 61.98M 2026-09
Teva Pharmaceutical Industries USD 15.42B 221M 2026-09
Xeris Pharmaceuticals USD 134.48M 55.09M 2026-09
Zoetis USD 2.68B 621M 2026-09